Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quaker BioVentures is an active Philadelphia-based venture capital firm founded in 2002 that invests primarily in life science companies across biopharmaceuticals, medical devices, diagnostics, specialty pharmaceuticals, and healthcare services. The firm manages over $700 million in committed capital and has invested through multiple funds since inception. It targets companies at all development stages from early startups to public firms and has participated in more than 100 investments with over 30 portfolio exits including IPOs and acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quaker BioVentures.